New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 26, 2013
11:02 EDTCEDC, EXPD, MELI, IPXL, EWIHigh option volume stocks: EXPD EWI MELI CEDC IPXL
News For EXPD;EWI;MELI;CEDC;IPXL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 10, 2016
09:52 EDTEXPDExpeditors estimates remain below consensus at Cleveland Research
Subscribe for More Information
February 3, 2016
11:37 EDTMELIOptions with increasing put volume; PSX CDNS DF WDR MELI MAS NOV WSM DB
Subscribe for More Information
February 2, 2016
07:36 EDTIPXLImpax receives tentative FDA approval for generic Vytorin ANDA
Impax Laboratories announced that Impax has received tentative approval from the U.S. FDA for its Abbreviated New Drug Application for the generic version of the ezetimibe and simvastatin containing tablets, in 10 mg / 10 mg, 10 mg / 20 mg, 10 mg / 40 mg and 10 mg / 80 mg strengths. "We are pleased to receive tentative approval from the FDA for our generic version of Vytorin tablets," said Fred Wilkinson, President and CEO. "We will continue to work with the FDA to gain final approval upon the expiration of the U.S. patents and associated pediatric exclusivity on April 25, 2017, and are currently planning to be among the first generic products to market."

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use